Hot Features
Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
| Datum | Name des Inhabers | Gehandelte Aktien | Wertspanne ($) | Transaktionstyp | Preisspanne ($) | Aktien am Meldungsende | % Veränderung |
|---|---|---|---|---|---|---|---|
| 2026-06-16 | Mr. Wang LaiPresident and Global Head of Research & Development | -1,17k | 310,24k | Verkauf | 265,39 | 0,00 | -100,00% |
| 2026-06-16 | Mr. Chan LeeGeneral Counsel, Senior VP & Corporate Secretary | -590,00 | 156,93k | Verkauf | 265,98 | 0,00 | -100,00% |
| 2026-06-16 | Mr. John V. OylerCo-Founder, Executive Chairman & CEO | -3,69k | 980,69k | Verkauf | 264,87 - 266,69 | 0,00 | -100,00% |
| 2026-06-16 | Dr. Xiaobin WuInsider | -1,36k | 362,00k | Verkauf | 266,76 | 16,37k | -7,66% |
| 2026-06-11 | Mr. Titus B. BallVP & CAO | -169,00 | 43,47k | Verkauf | 256,39 - 257,53 | 0,00 | -100,00% |
| 2026-06-11 | Mr. Wang LaiPresident and Global Head of Research & Development | -756,00 | 197,32k | Verkauf | 261,00 | 0,00 | -100,00% |
| 2026-06-11 | Mr. John V. OylerCo-Founder, Executive Chairman & CEO | -1,95k | 501,35k | Verkauf | 256,23 - 258,81 | 0,00 | -100,00% |
| 2026-06-11 | Mr. Aaron RosenbergCFO | -631,00 | 162,64k | Verkauf | 257,74 | 0,00 | -100,00% |
| 2026-06-11 | Mr. Chan LeeGeneral Counsel, Senior VP & Corporate Secretary | -428,00 | 110,27k | Verkauf | 257,64 | 0,00 | -100,00% |
| 2026-06-11 | Dr. Xiaobin WuInsider | -626,00 | 163,51k | Verkauf | 261,20 | 16,37k | -3,68% |
| 2026-06-08 | Mr. Titus B. BallVP & CAO | -136,00 | 36,90k | Verkauf | 271,06 - 272,08 | 0,00 | -100,00% |
| 2026-06-08 | Mr. Chan LeeGeneral Counsel, Senior VP & Corporate Secretary | -871,00 | 235,54k | Verkauf | 270,24 - 271,26 | 0,00 | -100,00% |
| 2026-06-08 | Mr. Wang LaiPresident and Global Head of Research & Development | -1,37k | 368,25k | Verkauf | 269,34 - 270,73 | 0,00 | -100,00% |
| 2026-06-08 | Dr. Xiaobin WuInsider | -1,48k | 399,74k | Verkauf | 269,33 - 270,55 | 16,37k | -8,31% |
| 2026-06-08 | Mr. John V. OylerCo-Founder, Executive Chairman & CEO | -4,94k | 1,34M | Verkauf | 270,38 - 271,14 | 0,00 | -100,00% |
| 2026-05-21 | Mr. Qingqing YiInsider | 10,99k | 0,00 | Derivative Exercise and Retained Stock | - | 27,33k | 67,22% |
| 2026-06-01 | Mr. Qingqing YiInsider | -235,00 | 65,60k | Verkauf | 279,13 | 0,00 | -100,00% |
| 2026-05-21 | Dr. Corazon Dating SandersInsider | 10,99k | 0,00 | Derivative Exercise and Retained Stock | - | 57,23k | 23,76% |
| 2026-05-21 | Dr. Alessandro RivaMember of Scientific Advisory Committee & Director | 10,99k | 0,00 | Derivative Exercise and Retained Stock | - | 56,94k | 23,90% |
| 2026-05-21 | Dr. Margaret Han DuganMember of Scientific Advisory Committee & Independent Non-Exec. Director | 10,99k | 0,00 | Derivative Exercise and Retained Stock | - | 56,94k | 23,90% |
| 2026-05-22 | Dr. Alessandro RivaMember of Scientific Advisory Committee & Director | -212,00 | 65,62k | Verkauf | 309,51 | 0,00 | -100,00% |
| 2026-05-22 | Dr. Margaret Han DuganMember of Scientific Advisory Committee & Independent Non-Exec. Director | -212,00 | 65,64k | Verkauf | 309,60 | 0,00 | -100,00% |
| 2026-05-22 | Dr. Corazon Dating SandersInsider | -212,00 | 65,63k | Verkauf | 309,59 | 0,00 | -100,00% |
| 2026-05-22 | Mr. Michael J. GollerInsider | -2,74k | 65,42k | Verkauf | 23,85 | 71,28k | -3,71% |
| 2026-05-22 | Mr. Ranjeev KrishanaInsider | -2,76k | 65,57k | Verkauf | 23,79 | 71,27k | -3,72% |
| 2026-05-21 | Mr. Michael J. GollerInsider | 10,99k | 0,00 | Derivative Exercise and Retained Stock | - | 74,02k | 17,43% |
| 2026-05-21 | Mr. Ranjeev KrishanaInsider | 10,99k | 0,00 | Derivative Exercise and Retained Stock | - | 74,02k | 17,43% |
| 2026-05-20 | Capital Research and Management CompanyUnternehmen | 72,54k | 21,91M | Kauf | 302,13 | 6,54M | 1,12% |
| 2026-05-13 | Mr. Chan LeeGeneral Counsel, Senior VP & Corporate Secretary | -332,00 | 39,56k | Derivative Exercise and Sale | 159,03 - 310,72 | 0,00 | - |
| 2026-05-07 | JPMorgan Chase & Co.Unternehmen | 406,08k | 9,85M | Kauf | 24,26 | 23,19k | -106,06% |
| 2026-05-05 | JPMorgan Chase & Co.Unternehmen | -706,53k | 15,88M | Verkauf | 22,47 | 119,23k | -85,56% |
| 2026-04-08 | Mr. Chan LeeGeneral Counsel, Senior VP & Corporate Secretary | -332,00 | 39,85k | Derivative Exercise and Sale | 159,03 - 311,59 | 0,00 | - |
| 2026-03-11 | Mr. Chan LeeGeneral Counsel, Senior VP & Corporate Secretary | -341,00 | 36,95k | Derivative Exercise and Sale | 159,03 - 300,00 | 0,00 | - |
| 2026-02-04 | Mr. Chan LeeGeneral Counsel, Senior VP & Corporate Secretary | -1,66k | 262,48k | Derivative Exercise and Sale | 159,03 - 350,00 | 0,00 | - |
| 2026-02-03 | JPMorgan Chase & Co.Unternehmen | 1,04M | 27,38M | Kauf | 26,23 | 2,26M | 85,78% |
| 2026-01-15 | JPMorgan Chase & Co.Unternehmen | 35,57k | 938,72k | Kauf | 26,39 | 236,26k | 17,73% |
| 2026-01-15 | JPMorgan Chase & Co.Unternehmen | 1,55M | 40,93M | Kauf | 26,39 | 2,36M | 191,64% |
| 2026-01-15 | JPMorgan Chase & Co.Unternehmen | -191,33k | 5,05M | Verkauf | 26,39 | 2,36M | -7,50% |
| 2026-01-16 | JPMorgan Chase & Co.Unternehmen | 28,69k | 746,29k | Kauf | 26,01 | 253,90k | 12,74% |
| 2026-01-16 | JPMorgan Chase & Co.Unternehmen | -117,00 | 3,04k | Verkauf | 26,01 | 253,90k | -0,05% |
| 2026-01-16 | JPMorgan Chase & Co.Unternehmen | -1,67M | 43,53M | Verkauf | 26,01 | 711,32k | -70,17% |
| 2026-01-14 | JP Morgan Asset ManagementUnternehmen | -3,90k | 103,29k | Verkauf | 26,48 | 55,92k | -6,52% |
| 2026-01-14 | JPMorgan Chase & Co.Unternehmen | 9,25k | 245,09k | Kauf | 26,48 | 202,24k | 4,80% |
| 2026-01-14 | JPMorgan Chase & Co.Unternehmen | -4,89k | 129,46k | Verkauf | 26,48 | 202,24k | -2,36% |
| 2026-01-14 | JPMorgan Chase & Co.Unternehmen | 167,86k | 4,45M | Kauf | 26,48 | 783,04k | 27,29% |
| 2026-01-14 | JPMorgan Chase & Co.Unternehmen | -1,94M | 51,30M | Verkauf | 26,48 | 783,04k | -71,21% |
| 2026-01-08 | JPMorgan Chase & Co.Unternehmen | -546,40k | 0,00 | Other Disposition | - | 769,48k | -41,52% |
| 2026-01-07 | Mr. Chan LeeGeneral Counsel, Senior VP & Corporate Secretary | -664,00 | 93,09k | Derivative Exercise and Sale | 159,03 - 331,76 | 0,00 | - |
| 2025-12-31 | Mr. Anthony C. HooperChairman of Commercial & Medical Affairs Advisory Committee and Ind. Non Executive Director | 12,92k | 0,00 | Derivative Exercise and Retained Stock | - | 37,41k | 52,76% |
| 2025-12-19 | JPMorgan Chase & Co.Unternehmen | -140,55k | 0,00 | Other Disposition | - | 798,45k | -14,97% |
| 2025-12-16 | JPMorgan Chase & Co.Unternehmen | -762,99k | 0,00 | Other Disposition | - | 258,01k | -74,73% |
| 2025-12-16 | JPMorgan Chase & Co.Unternehmen | -15,81k | 0,00 | Other Disposition | - | 1,79M | -0,88% |
| 2025-12-15 | JPMorgan Chase & Co.Unternehmen | -598,45k | 0,00 | Other Disposition | - | 1,47M | -28,86% |
| 2025-12-11 | JP Morgan Asset ManagementUnternehmen | -500,00 | 0,00 | Other Disposition | - | -500,00 | - |
| 2025-12-11 | JPMorgan Chase & Co.Unternehmen | -171,98k | 0,00 | Other Disposition | - | 1,04M | -14,20% |
| 2025-12-15 | Mr. John V. OylerCo-Founder, Executive Chairman & CEO | -100,00k | 30,66M | Automatic Disposition | 300,80 - 314,92 | 0,00 | -100,00% |
| 2025-12-10 | JPMorgan Chase & Co.Unternehmen | -508,02k | 0,00 | Other Disposition | - | 1,40M | -26,65% |
| 2025-12-10 | Mr. Chan LeeGeneral Counsel, Senior VP & Corporate Secretary | -664,00 | 86,37k | Derivative Exercise and Sale | 159,03 - 325,00 | 0,00 | - |
| 2025-11-26 | Dr. Corazon Dating SandersInsider | -2,63k | 477,76k | Derivative Exercise and Sale | 159,03 - 342,47 | 0,00 | - |
| 2025-11-13 | JPMorgan Chase & Co.Unternehmen | -771,57k | 0,00 | Other Disposition | - | 2,48M | -23,73% |
| 2025-11-17 | Dr. Xiaobin WuInsider | -3,99k | 1,52M | Verkauf | 380,23 - 382,32 | 16,37k | -19,61% |
| 2025-11-12 | Dr. Xiaobin WuInsider | -16,01k | 5,85M | Verkauf | 350,44 - 381,05 | 16,37k | -49,45% |
| 2025-11-12 | Mr. Chan LeeGeneral Counsel, Senior VP & Corporate Secretary | -996,00 | 157,07k | Derivative Exercise and Sale | 159,03 - 350,00 | 0,00 | - |
| 2025-11-11 | Mr. John V. OylerCo-Founder, Executive Chairman & CEO | -1,01M | 0,00 | Other Disposition | - | 51,48M | -1,92% |
| 2025-11-07 | Dr. Xiaodong WangCo-Chairman of Scientific Advisory Board, Non-Executive Director & Co-Founder | -424,07k | 0,00 | Other Disposition | - | 9,32M | -4,35% |
| 2025-10-21 | JPMorgan Chase & Co.Unternehmen | -9,47k | 0,00 | Other Disposition | - | 1,59M | -0,59% |
| 2025-10-15 | JPMorgan Chase & Co.Unternehmen | -22,95k | 0,00 | Other Disposition | - | 270,26k | -7,83% |
| 2025-10-15 | JPMorgan Chase & Co.Unternehmen | -136,97k | 0,00 | Other Disposition | - | 1,54M | -8,19% |
| 2025-10-14 | JPMorgan Chase & Co.Unternehmen | -97,34k | 0,00 | Other Disposition | - | 271,74k | -26,37% |
| 2025-10-14 | JPMorgan Chase & Co.Unternehmen | -1,60k | 0,00 | Other Disposition | - | 1,54M | -0,10% |
| 2025-10-13 | JPMorgan Chase & Co.Unternehmen | -615,48k | 0,00 | Other Disposition | - | 1,52M | -28,79% |
| 2025-10-08 | Mr. Chan LeeGeneral Counsel, Senior VP & Corporate Secretary | -9,56k | 1,33M | Derivative Exercise and Sale | 159,03 - 351,12 | - | - |
| 2025-10-08 | Mr. Chan LeeGeneral Counsel, Senior VP & Corporate Secretary | -1,11k | 389,20k | Automatic Disposition | 350,00 | 0,00 | -100,00% |
| 2025-09-22 | JPMorgan Chase & Co.Unternehmen | -35,06k | 0,00 | Other Disposition | - | 277,27k | -11,23% |
| 2025-09-22 | JPMorgan Chase & Co.Unternehmen | -399,98k | 0,00 | Other Disposition | - | 2,06M | -16,24% |
| 2025-09-17 | JPMorgan Chase & Co.Unternehmen | -24,28k | 0,00 | Other Disposition | - | 274,35k | -8,13% |
| 2025-09-17 | JPMorgan Chase & Co.Unternehmen | -346,93k | 0,00 | Other Disposition | - | 1,95M | -15,10% |
| 2025-09-16 | Mr. John V. OylerCo-Founder, Executive Chairman & CEO | -27,80k | 9,06M | Automatic Disposition | 324,12 - 327,78 | 0,00 | -100,00% |
| 2025-09-12 | JPMorgan Chase & Co.Unternehmen | -671,57k | 0,00 | Other Disposition | - | 1,75M | -27,70% |
| 2025-09-10 | Mr. Chan LeeGeneral Counsel, Senior VP & Corporate Secretary | -8,89k | 1,14M | Derivative Exercise and Sale | 159,03 - 327,93 | 0,00 | - |
| 2025-09-10 | Mr. Chan LeeGeneral Counsel, Senior VP & Corporate Secretary | -1,11k | 361,40k | Automatic Disposition | 325,00 | 0,00 | -100,00% |
| 2025-09-09 | JPMorgan Chase & Co.Unternehmen | -208,12k | 0,00 | Other Disposition | - | 1,73M | -10,76% |
| 2025-09-09 | Dr. Xiaodong WangCo-Chairman of Scientific Advisory Board, Non-Executive Director & Co-Founder | -148,10k | 0,00 | Other Disposition | - | 9,74M | -1,50% |
| 2025-09-09 | Mr. Wang LaiPresident and Global Head of Research & Development | -5,00k | 1,75M | Automatic Disposition | 350,06 | 0,00 | -100,00% |
| 2025-09-09 | Capital Research and Management CompanyUnternehmen | 67,88k | 3,03M | Kauf | 44,70 | 5,32M | 1,29% |
| 2025-09-05 | Dr. Corazon Dating SandersInsider | -2,67k | 483,22k | Derivative Exercise and Sale | 155,68 - 337,00 | 0,00 | - |
| 2025-09-02 | Mr. Titus B. BallVP & CAO | -122,00 | 39,86k | Verkauf | 326,76 | 0,00 | -100,00% |
| 2025-08-13 | Dr. Xiaobin WuInsider | -89,79k | 12,91M | Derivative Exercise and Sale | 155,68 - 308,03 | 16,37k | - |
| 2025-08-13 | Mr. Chan LeeGeneral Counsel, Senior VP & Corporate Secretary | -8,23k | 1,01M | Derivative Exercise and Sale | 159,03 - 301,00 | 0,00 | - |
| 2025-08-13 | Mr. Chan LeeGeneral Counsel, Senior VP & Corporate Secretary | -2,78k | 836,57k | Automatic Disposition | 300,00 - 301,00 | 0,00 | -100,00% |
| 2025-08-11 | Capital Research and Management CompanyUnternehmen | -55,08k | 15,89M | Verkauf | 288,52 | 5,21M | -1,05% |
| 2025-08-01 | Mr. Aaron RosenbergCFO | -1,19k | 345,66k | Verkauf | 290,47 | 0,00 | -100,00% |
| 2025-07-29 | Mr. Wang LaiPresident and Global Head of Research & Development | -4,30k | 1,30M | Automatic Disposition | 302,00 - 305,00 | 0,00 | -100,00% |
| 2025-07-30 | Mr. Chan LeeGeneral Counsel, Senior VP & Corporate Secretary | -920,00 | 280,23k | Verkauf | 304,60 | 0,00 | -100,00% |
| 2025-07-18 | Mr. Wang LaiPresident and Global Head of Research & Development | -700,00 | 210,00k | Automatic Disposition | 300,00 | 0,00 | -100,00% |
| 2025-07-17 | JPMorgan Chase & Co.Unternehmen | -794,20k | 0,00 | Other Disposition | - | 1,29M | -38,16% |
| 2025-07-09 | Mr. John V. OylerCo-Founder, Executive Chairman & CEO | -27,80k | 7,04M | Automatic Disposition | 252,23 - 254,83 | 0,00 | -100,00% |
Die zuletzt besuchten Aktien werden in diesem Feld angezeigt, so dass Sie leicht zu den Aktien zurückkehren können, die Sie zuvor angesehen haben.
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Mit E-Mail registrieren
Haben Sie schon ein Konto? Anmelden
Haben Sie kein Konto? Registrieren
Durch die Registrierung bestätige ich, dass ich die Allgemeinen Geschäftsbedingungen von ADVFN gelesen und verstanden habe und ihnen zustimme und dass ich ein Privatinvestor bin.
Premium
